Glen A. Taylor - 11 Mar 2025 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role
Director, 10%+ Owner
Signature
/s/ Andrew Nick as Attorney-in-Fact for Glen A. Taylor pursuant to a Power of Attorney previously filed
Issuer symbol
COCH
Transactions as of
11 Mar 2025
Net transactions value
$0
Form type
4
Filing time
13 Mar 2025, 16:06:56 UTC
Previous filing
17 Dec 2024
Next filing
08 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding COCH Class A Common Stock 2,953,607 11 Mar 2025 Direct
holding COCH Class A Common Stock 2,526,058 11 Mar 2025 By Taylor Sports Group F1
holding COCH Class A Common Stock 4,810,384 11 Mar 2025 By GAT Funding, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCH Warrant (right to buy) Award $0 +750,000 $0.000000 750,000 11 Mar 2025 Class A Common Stock 750,000 $1.35 GAT Funding, LLC F2, F4
holding COCH Series A Preferred Stock 1,000,000 11 Mar 2025 Class A Common Stock 869,565 $11.50 GAT Funding, LLC F2, F3
holding COCH Warrant (right to buy) 500,000 11 Mar 2025 Class A Common Stock 500,000 $1.24 GAT Funding, LLC F2
holding COCH Warrant (right to buy) 250,000 11 Mar 2025 Class A Common Stock 250,000 $3.04 GAT Funding, LLC F2
holding COCH Warrant (right to buy) 250,000 11 Mar 2025 Class A Common Stock 250,000 $2.25 GAT Funding, LLC F2
holding COCH Warrant (right to buy) 500,000 11 Mar 2025 Class A Common Stock 500,000 $2.97 GAT Funding, LLC F2
holding COCH Warrant (right to buy) 500,000 11 Mar 2025 Class A Common Stock 500,000 $2.20 GAT Funding, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the owner and chairman of Taylor Sports Group.
F2 GAT Funding, LLC is an entity controlled by the Reporting Person.
F3 Fully exercisable and there is no expiration date.
F4 In connection with the promissory note issuance effective March 6, 2025 and the closing of the initial funding on March 11, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on March 12, 2025.